期刊文献+

2型糖尿病患者血清胱抑素C与低心率变异性的相关性研究 被引量:11

Relationship between serum cystatin C and reduced heart rate variability in type 2 diabetic patients
原文传递
导出
摘要 目的探讨T2DM患者血清胱抑素C(Cys-C)与心率变异性(HRV)的相关性。方法选取T2DM患者222例,根据Cys-C分为高Cys-C(n=112)和低Cys-C组(n=110)。免疫比浊法检测Cys-C,24h动态心电图评估HRV。结果高Cys-C组5min心搏间期均值的标准差(SDANN)低于低Cys-C组[109(89,136)vs 132(105,187)m/s,P<0.05]。多元线性回归分析显示,Cys-C(log)与SDANN(log)(β=-0.395,P<0.01)、低频/高频(LF/HF)(log)(β=-0.141,P<0.01)、总功率TP(log)(β=-0.174,P<0.01)独立相关。结论 T2DM患者血Cys-C与HRV指标(SDANN、LF/HF、TP)呈负相关,提示高Cys-C与糖尿病心脏自主神经病变(DCAN)相关。 Objective To investigate the relationship between serum cystatin C(Cys-C)and heart rate variability(HRV)in patients with type 2diabetes mellitus(T2DM). Methods 222T2 DM patients were enrolled in this cross-sectional study.Patients were divided into two groups according to the levels of serum Cys-C:the higher group(n=112)and the lower group(n=110).Serum Cys-C was determined by immune-turbidimetric method.24-h Holter monitoring was performed for HRV analysis. Results The higher Cys-C group had less SDANN than the lower Cys-C group[109(89,136)vs 132(105,187)m/s,P〈0.05].In multiple linear regression,Cys-C(log)was independently associated with SDANN(log)(β=-0.395,P〈0.01),LF/HF(log)(β=-0.141,P〈0.01)and TP(log)(β=-0.174,P〈0.01).Conclusion Reduced HRV parameters(SDANN,LF/HF,TP),which reflect cardiovascular autonomic imbalance,are closely related to serum Cys-C in T2 DM.These findings means high level of Cys-C is associated with DCAN(diabetic cardiac autonomic neuropathy).
作者 石薇 张静 段微 陈晓蕾 SHI Wei ZHANG Jing DUAN Wei et al(Department of Endocrinology, Hubei Integrated TCM & WM Hospital , Wuhan 430015 ,China)
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2017年第3期245-249,共5页 Chinese Journal of Diabetes
关键词 血清胱抑素C 糖尿病 2型 心率变异性 心脏自主神经病变 Cystatin C(Cys-C) Diabetes mellitus,type 2 Heart rate variability(HRV) Cardiac autonomic neuropathy(CAN)
  • 相关文献

参考文献3

二级参考文献29

  • 1康素娴,卢亚敏,张冬会,毕建成.肥胖与伴有糖尿病患者的胰高血糖素和胰岛素含量探讨[J].检验医学与临床,2007,4(11):1061-1062. 被引量:2
  • 2Nagesh CM, Roy A. Role of biomarkers in risk stratification of a- cute coronary syndmme. Indian J Med Res, 2010,132 : 627-633. 被引量:1
  • 3Taglieri N, Koenig W, Kaski JC. Cystatin C and cardiovasculao risk. Clin Chem, 2009,55 : 1932-1943. 被引量:1
  • 4Brown TM, Billner V. Bi, markers of athemsclerosis:clnical ap- plications. Curr Cardiol Rep, 2008,10 : 497-504. 被引量:1
  • 5Ni L, Lu J, Hou LB, et al. Cystatin C, associated with hemor- rhagic and ischemic stroke, is a strong predictor of the risk of cardiovascular events and death in Chinese. Stroke,2007,38: 3287-3288. 被引量:1
  • 6Luc G, Bard JM, lesueur C, et al. Plasma Cystatin C and devel- opment of coronaryheart disease: The PRIME Study. Atheroscle- rosis, 2006,185 : 375-380. 被引量:1
  • 7Ogawa Y, Goto T, Tamasawa N, et al. Serum eystatin c in dia- betic patients. Not only an indicator for renal dysfunction in pa- tients with overtnephmpathy but also a predictor for cardiovascu- lar events in patients without nephropathy. Diabetes Res Clin Praet, 2008,79 : 357-361. 被引量:1
  • 8Muntner P,Winston J,Uribarri J. Overweight,obesity,and el- evated serum eystatin C levels in adults in the United States. Am J Med, 2008,121 : 341-348. 被引量:1
  • 9Nordquist L, Brown R, Fasching A, et al. Proinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorp- tion. Am J Physiol Renal Physiol, 2009,297 .. F1265-F1272. 被引量:1
  • 10John M, Lachin, Viberti G, et al. Renal function in type 2 dia- betes with rosiglitazone, metformin, and glyburide monothera- py. Clin J Am Soc Nephrol, 2011,6 : 1032-1040. 被引量:1

共引文献21

同被引文献95

引证文献11

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部